GR3026619T3 - Inactivated respiratory syncytial viral vaccines - Google Patents

Inactivated respiratory syncytial viral vaccines

Info

Publication number
GR3026619T3
GR3026619T3 GR980400815T GR980400815T GR3026619T3 GR 3026619 T3 GR3026619 T3 GR 3026619T3 GR 980400815 T GR980400815 T GR 980400815T GR 980400815 T GR980400815 T GR 980400815T GR 3026619 T3 GR3026619 T3 GR 3026619T3
Authority
GR
Greece
Prior art keywords
virus
inactivated
immunogenic composition
respiratory syncytial
purified
Prior art date
Application number
GR980400815T
Other languages
English (en)
Inventor
Sonia E Sanhueza
Mary Elizabeth Ewasyshyn
Michel Henri Klein
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Publication of GR3026619T3 publication Critical patent/GR3026619T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18551—Methods of production or purification of viral material
GR980400815T 1993-08-06 1998-04-10 Inactivated respiratory syncytial viral vaccines GR3026619T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10274293A 1993-08-06 1993-08-06
PCT/CA1994/000425 WO1995004545A1 (en) 1993-08-06 1994-08-04 Inactivated respiratory syncytial viral vaccines

Publications (1)

Publication Number Publication Date
GR3026619T3 true GR3026619T3 (en) 1998-07-31

Family

ID=22291469

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400815T GR3026619T3 (en) 1993-08-06 1998-04-10 Inactivated respiratory syncytial viral vaccines

Country Status (15)

Country Link
US (1) US7083795B1 (el)
EP (1) EP0714306B1 (el)
JP (1) JP4053587B2 (el)
KR (1) KR100402379B1 (el)
CN (1) CN1103603C (el)
AT (1) ATE164313T1 (el)
AU (1) AU677090B2 (el)
BR (1) BR9407182A (el)
CA (1) CA2167274C (el)
DE (1) DE69409243T2 (el)
DK (1) DK0714306T3 (el)
ES (1) ES2113670T3 (el)
GR (1) GR3026619T3 (el)
RU (1) RU2142817C1 (el)
WO (1) WO1995004545A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4243491A1 (de) * 1992-12-22 1994-06-23 Behringwerke Ag Verfahren zur Reinigung und Anreicherung von Rubella-Virus
DK2590675T3 (en) * 2010-07-07 2018-10-29 Artificial Cell Tech Inc ANTI-ANTI-COMPOSITIONS AND PROCEDURES FOR RESPIRATORY SYNCYTIAL VIRUS
EP4072582A4 (en) * 2019-12-10 2023-05-24 Repligen Corporation PROCESS FOR PREPARING VIRAL VECTORS
EP4281065A1 (en) 2021-01-20 2023-11-29 Alto Neuroscience, Inc. Enhancement of camp signaling as a combination drug strategy for the treatment of depression and related conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3164143D1 (en) * 1980-07-01 1984-07-19 Nat Res Dev Production of viral antigens
US4591505A (en) * 1982-04-14 1986-05-27 New York Blood Center, Inc. Process for inactivating hepatitis B virus
US4664912A (en) 1984-10-01 1987-05-12 Wiktor Tadeusz J Process for the large scale production of rabies vaccine
US4790987A (en) 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
US4732683A (en) * 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
NZ226332A (en) * 1987-09-28 1991-10-25 Beecham Inc Vaccine comprising transmissible gastroenteritis virus of swine for preventing canine coronavirus infection in dogs and process for preparation thereof
US5200179A (en) * 1987-09-28 1993-04-06 Beecham Group P.L.C. Vaccine
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
GB8914968D0 (en) 1989-06-29 1989-08-23 Connaught Lab Production of virus and purification of viral envelope proteins for vaccine use
IL105456A (en) 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus

Also Published As

Publication number Publication date
RU2142817C1 (ru) 1999-12-20
ES2113670T3 (es) 1998-05-01
EP0714306B1 (en) 1998-03-25
CA2167274C (en) 2007-11-27
US7083795B1 (en) 2006-08-01
AU7380194A (en) 1995-02-28
CN1133013A (zh) 1996-10-09
DE69409243D1 (de) 1998-04-30
EP0714306A1 (en) 1996-06-05
DE69409243T2 (de) 1998-08-06
ATE164313T1 (de) 1998-04-15
KR100402379B1 (ko) 2004-03-24
CA2167274A1 (en) 1995-02-16
KR960703618A (ko) 1996-08-31
DK0714306T3 (da) 1998-10-19
JP4053587B2 (ja) 2008-02-27
CN1103603C (zh) 2003-03-26
AU677090B2 (en) 1997-04-10
JPH09501912A (ja) 1997-02-25
WO1995004545A1 (en) 1995-02-16
BR9407182A (pt) 1996-09-17

Similar Documents

Publication Publication Date Title
HUT69803A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
ES2074950A1 (es) Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
HK37397A (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
EP0342860A3 (en) Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use
EP0480949B2 (en) Production of viral vaccine
ATE422364T1 (de) Multivalente immunogenische zusammensetzung, die eine rsv untereinheit zusammensetzung und ein influenzavirus präparat enthält
GR3026619T3 (en) Inactivated respiratory syncytial viral vaccines
CA2302833A1 (en) Peptides derived from the attachment (g) protein of respiratory syncytial virus
ATE354370T1 (de) Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen
NO970847D0 (no) 2-£amino-6-(cyklopropylamino)-9H-purin-9-yl|-2-cyklopenten-1-metanol-succinat som anti-virusmiddel
Stittelaar et al. Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates
WO1995012682A3 (en) Viral vector with bovine viral diarrhea virus (bvdv) antigens
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
WO2004083397A3 (en) Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv
ES8404188A1 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
NL300073I1 (nl) Vaccin.
EP0668356A3 (en) Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same
KR960016906A (ko) 약독화 수두 생바이러스 백신 및 그의 제조방법
Teokhorova et al. Clinical and immunological studies in the use of an experimental lot of hepatitis B vaccine.
EP0178928A3 (en) Vaccines